Neurocrine Biosciences Inc (NBIX) announced a profit for its second quarter that Increased from the same period last year and beat the Street estimates.
The company's bottom line came in at $107.5 million, or $1.06 per share. This compares with $65.0 million, or $0.63 per share, last year.
Excluding items, Neurocrine Biosciences Inc reported adjusted earnings of $166.2 million or $1.65 per share for the period.
Analysts on average had expected the company to earn $1.50 per share. Analysts' estimates typically exclude special items.
The company's revenue for the period rose 16.5% to $687.5 million from $590.2 million last year.
Neurocrine Biosciences Inc earnings at a glance (GAAP) :
-Earnings: $107.5 Mln. vs. $65.0 Mln. last year.
-EPS: $1.06 vs. $0.63 last year.
-Revenue: $687.5 Mln vs. $590.2 Mln last year.
https://www.rttnews.com/3559743/neurocrine-biosciences-inc-q2-profit-increases-beats-estimates.aspx
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.